Correction: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene

Read full text
Authors: Jun Zhang, Zhijia Tang, Xi Guo, Yunxia Wang, Yuhong Zhou, Weimin Cai
Cited by: 0

Abstract

Corrigendum on: Zhang J, Tang Z, Guo X, Wang Y, Zhou Y and Cai W (2022) Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene. Front. Oncol. 12:933646. doi: 10.3389/fonc.2022.933646In the published article, there was an error in the Funding statement. The original text is "This work was supported by grant from the National Natural Science Foundation of China [Grant No. 8217130423].", but the correct funding number should be 82173892.When we were concluding the fund project, we found that the funding number marked on the published article was mistakenly the project's acceptance number instead of the correct approval number. The correct Funding statement appears below.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations PI3K/AKT/mTOR signaling in cancer

Publication details

Journal / source
Frontiers in Oncology
Volume
16
Pages
1815252–1815252
Publication date
3 March 2026
Language
EN